Skip to main content
main-content

Zeitschrift

Hepatology International

Hepatology International 2/2021

Ausgabe 2/2021

Inhaltsverzeichnis ( 31 Artikel )

04.05.2021 | Guidelines | Ausgabe 2/2021 Open Access

The Asian Pacific Association for the Study of the Liver clinical practice guidance: the diagnosis and management of patients with autoimmune hepatitis

Guiqiang Wang, Atsushi Tanaka, Hong Zhao, Jidong Jia, Xiong Ma, Kenichi Harada, Fu-Sheng Wang, Lai Wei, Qixia Wang, Ying Sun, Yuan Hong, Huiying Rao, Cumali Efe, George Lau, Diana Payawal, Rino Gani, Keith Lindor, Wasim Jafri, Masao Omata, Shiv Kumar Sarin

27.02.2021 | Guidelines | Ausgabe 2/2021

Drug-induced liver injury: Asia Pacific Association of Study of Liver consensus guidelines

Harshad Devarbhavi, Guruprasad Aithal, Sombat Treeprasertsuk, Hajime Takikawa, Yimin Mao, Saggere M. Shasthry, Saeed Hamid, Soek Siam Tan, Cyriac Abby Philips, Jacob George, Wasim Jafri, Shiv K. Sarin, on behalf of the Asia Pacific Association of Study of Liver

01.02.2021 | Editorial | Ausgabe 2/2021 Open Access

Targeting the ileal bile salt transporter in the treatment of non-alcoholic fatty liver disease

Peter L. M. Jansen

13.03.2021 | Editorial | Ausgabe 2/2021

Toward a new landscape for the mechanism of immunosuppression in hepatocellular carcinoma

Chien-Wei Su, Han-Chieh Lin

27.02.2021 | Review Article | Ausgabe 2/2021

Chronic hepatitis B: the demise of the ‘inactive carrier’ phase

Apostolos Koffas, Manoj Kumar, Upkar S. Gill, Ankur Jindal, Patrick T. F. Kennedy, S. K. Sarin

04.03.2021 | Original Article | Ausgabe 2/2021

Combining end-of-treatment HBsAg and baseline hepatitis B core-related antigen reduce HBV relapse rate after tenofovir cessation

Yuan-Hung Kuo, Jing-Houng Wang, Chao-Hung Hung, Sheng-Nan Lu, Tsung-Hui Hu, Chien-Hung Chen

27.04.2021 | Original Article | Ausgabe 2/2021

A novel evidence of serial changes of bone mineral density in chronic hepatitis B patients treated with entecavir

Pao-Yuan Huang, Sherry Yueh-Hsia Chiu, Kuo-Chin Chang, Po-Lin Tseng, Yi-Hao Yen, Ming-Chao Tsai, Jing-Houng Wang, Kwong-Ming Kee, Chien-Hung Chen, Chao-Hung Hung, King-Wah Chiu, Tsung-Hui Hu

26.02.2021 | Original Article | Ausgabe 2/2021

High-normal alanine aminotransferase is an indicator for liver histopathology in HBeAg-negative chronic hepatitis B

Menghui Duan, Xiaoling Chi, Huanming Xiao, Xueen Liu, Hui Zhuang

22.03.2021 | Original Article | Ausgabe 2/2021

Neonatal hepatitis B vaccination protects mature adults from occult virus infection

Ruijun Wang, Chang Liu, Taoyang Chen, Yuting Wang, Chunsun Fan, Lingling Lu, Fengmin Lu, Chunfeng Qu

06.03.2021 | Original Article | Ausgabe 2/2021

Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in Taiwan

Chen-Hua Liu, Po-Yueh Chen, Jyh-Jou Chen, Ching-Chu Lo, Wei-Wen Su, Kuo-Chih Tseng, Chun-Jen Liu, Chia-Sheng Huang, Ke-Jhang Huang, Sheng-Shun Yang, Cheng-Yuan Peng, Ming-Chang Tsai, Wei-Yu Kao, Chi-Yang Chang, Yu-Lueng Shih, Yu-Jen Fang, Chi-Yi Chen, Pei-Lun Lee, Jow-Jyh Huang, Pei-Yuan Su, Chi-Wei Tseng, Chien-Ching Hung, Chung-Hsin Chang, Yi-Jie Huang, Hsueh-Chou Lai, Chun-Chao Chang, Fu-Jen Lee, Tsai‐Yuan Hsieh, Jia-Horng Kao

03.03.2021 | Original Article | Ausgabe 2/2021 Open Access

Gut-liver axis modulation of Panax notoginseng saponins in nonalcoholic fatty liver disease

Yu Xu, Ning Wang, Hor-Yue Tan, Sha Li, Cheng Zhang, Yibin Feng

12.02.2021 | Original Article | Ausgabe 2/2021

The epidemiology of NAFLD and lean NAFLD in Japan: a meta-analysis with individual and forecasting analysis, 1995–2040

Takanori Ito, Masatoshi Ishigami, Biyao Zou, Taku Tanaka, Hirokazu Takahashi, Masayuki Kurosaki, Mayumi Maeda, Khin Naing Thin, Kenichi Tanaka, Yuka Takahashi, Yoshito Itoh, Kentaro Oniki, Yuya Seko, Junji Saruwatari, Miwa Kawanaka, Masanori Atsukawa, Hideyuki Hyogo, Masafumi Ono, Eiichi Ogawa, Scott D. Barnett, Christopher D. Stave, Ramsey C. Cheung, Mitsuhiro Fujishiro, Yuichiro Eguchi, Hidenori Toyoda, Mindie H. Nguyen

10.03.2021 | Original Article | Ausgabe 2/2021

Does the risk of cardiovascular events differ between biopsy-proven NAFLD and MAFLD?

Gabriel Tayguara Silveira Guerreiro, Larisse Longo, Mariana Alves Fonseca, Valessa Emanoele Gabriel de Souza, Mário Reis Álvares-da-Silva

04.01.2021 | Original Article | Ausgabe 2/2021

Elobixibat, an ileal bile acid transporter inhibitor, ameliorates non-alcoholic steatohepatitis in mice

Ryo Yamauchi, Hidetoshi Takedatsu, Keiji Yokoyama, Eri Yamauchi, Motoko Kawashima, Takahiro Nagata, Yotaro Uchida, Takanori Kitaguchi, Tomotaka Higashi, Hiromi Fukuda, Naoaki Tsuchiya, Kazuhide Takata, Takashi Tanaka, Daisuke Morihara, Yasuaki Takeyama, Satoshi Shakado, Shotaro Sakisaka, Fumihito Hirai

04.02.2021 | Original Article | Ausgabe 2/2021

The metabolic profiles and body composition of lean metabolic associated fatty liver disease

Yu-Ming Cheng, Jia-Horng Kao, Chia-Chi Wang

19.03.2021 | Original Article | Ausgabe 2/2021

Liver fibrosis scores and coronary atherosclerosis: novel findings in patients with stable coronary artery disease

Jing-Lu Jin, Hui-Wen Zhang, Ye-Xuan Cao, Hui-Hui Liu, Qi Hua, Yan-Fang Li, Yan Zhang, Yuan-Lin Guo, Na-Qiong Wu, Cheng-Gang Zhu, Rui-Xia Xu, Ying Gao, Chuan-Jue Cui, Geng Liu, Jing Sun, Qian Dong, Jian-Jun Li

16.04.2021 | Original Article | Ausgabe 2/2021

The longitudinal outcomes of applying non-selective beta-blockers in portal hypertension: real-world multicenter study

Seong Hee Kang, Minjong Lee, Moon Young Kim, Jun Hyeok Lee, Baek Gyu Jun, Tae Suk Kim, Dae Hee Choi, Ki Tae Suk, Young Don Kim, Gab Jin Cheon, Dong Joon Kim, Soon Koo Baik

16.04.2021 | Original Article | Ausgabe 2/2021

Paris II and Rotterdam criteria are the best predictors of outcomes in patients with primary biliary cholangitis in Japan

Naruhiro Kimura, Masaaki Takamura, Nobutaka Takeda, Yusuke Watanabe, Yoshihisa Arao, Masahumi Takatsuna, Suguru Takeuchi, Hiroyuki Abe, Toru Setsu, Hiroteru Kamimura, Akira Sakamaki, Kenya Kamimura, Atsunori Tsuchiya, Shuji Terai

21.11.2020 | Original Article | Ausgabe 2/2021

Dual targeting of PD-L1 and PD-L2 by PCED1B-AS1 via sponging hsa-miR-194-5p induces immunosuppression in hepatocellular carcinoma

Fei Fan, Keji Chen, Xiaoliang Lu, Aijun Li, Caifeng Liu, Bin Wu

03.02.2021 | Original Article | Ausgabe 2/2021

Development and validation of an individualized prediction calculator of postoperative mortality within 6 months after surgical resection for hepatocellular carcinoma: an international multicenter study

Lei Liang, Bing Quan, Han Wu, Yong-Kang Diao, Jie Li, Ting-Hao Chen, Yao-Ming Zhang, Ya-Hao Zhou, Wan-Guang Zhang, Hong Wang, Matteo Serenari, Matteo Cescon, Myron Schwartz, Yong-Yi Zeng, Ying-Jian Liang, Hang-Dong Jia, Hao Xing, Chao Li, Ming-Da Wang, Wen-Tao Yan, Wan-Yuan Chen, Wan Yee Lau, Cheng-Wu Zhang, Timothy M. Pawlik, Dong-Sheng Huang, Feng Shen, Tian Yang

05.02.2021 | Original Article | Ausgabe 2/2021

Clinical manifestations and outcomes of patients with scirrhous hepatocellular carcinoma

Shang-Chin Huang, Sih-Han Liao, Tung-Hung Su, Yung-Ming Jeng, Jia-Horng Kao

17.02.2021 | Original Article | Ausgabe 2/2021

Weight fluctuation and risk of hepatocellular carcinoma: a nationwide population-based 8-million-subject study

Young Chang, Jeong-Ju Yoo, Eun Ju Cho, Kyungdo Han, Dahye Kim, Bo-Yeon Kim, Goh Eun Chung, Yuri Cho, Dong Wook Shin, Su Jong Yu

03.02.2021 | COVID-19 | Original Article | Ausgabe 2/2021 Zur Zeit gratis

Liver injury predicts overall mortality in severe COVID-19: a prospective multicenter study in Brazil

Fernanda Manhães Pozzobon, Hugo Perazzo, Fernando Augusto Bozza, Rosana Souza Rodrigues, Renata de Mello Perez, Maria Chiara Chindamo

24.02.2021 | Original Article | Ausgabe 2/2021

Dynamic Optic Nerve Sheath Diameter (ONSD) guided management of raised intracranial pressure in pediatric acute liver failure

Priti Vijay, Bikrant Bihari Lal, Vikrant Sood, Rajeev Khanna, Yashwant Patidar, Seema Alam

25.02.2021 | Original Article | Ausgabe 2/2021 Open Access

Checkpoint inhibitor induced hepatitis and the relation with liver metastasis and outcome in advanced melanoma patients

Maaike Biewenga, Monique K. van der Kooij, Michel W. J. M. Wouters, Maureen J. B. Aarts, Franchette W. P. J. van den Berkmortel, Jan Willem B. de Groot, Marye J. Boers-Sonderen, Geke A. P. Hospers, Djura Piersma, Rozemarijn S. van Rijn, Karijn P. M. Suijkerbuijk, Albert J. ten Tije, Astrid A. M. van der Veldt, Gerard Vreugdenhil, John B. A. G. Haanen, Alfons J. M. van der Eertwegh, Bart van Hoek, Ellen Kapiteijn

29.01.2021 | Letter to the Editor | Ausgabe 2/2021

Thromboelastometry in patients with advanced chronic liver disease: a complex interplay

Sanchit Sharma

17.02.2021 | Letter to the Editor | Ausgabe 2/2021

Author’s reply to “Thromboelastometry in patients with advanced chronic liver disease: a complex interplay”

Pierre Raeven, Mattias Mandorfer, David Marek Baron, Thomas Reiberger, Benedikt Simbrunner

18.02.2021 | Letter to the Editor | Ausgabe 2/2021

The prevalence of occult HBV infection in immunized children with HBs Ag positive parents: a hospital based analysis

Srinith B. Patil, Manoj Kumar Sahu, Girish Kumar Pati

10.02.2021 | Letter to the Editor | Ausgabe 2/2021

C1QTNF1-AS1 regulates the occurrence and development of hepatocellular carcinoma by regulating miR-221-3p/SOCS3

Jiong Lin

27.04.2021 | Letter to the Editor | Ausgabe 2/2021

The main reasons for finite Nuc therapy in HBeAg-negative chronic hepatitis B patients

Chien-Wei Peng, Wen-Juei Jeng

22.04.2021 | Correction | Ausgabe 2/2021

Correction to: Targeting the ileal bile salt transporter in the treatment of non‑alcoholic fatty liver disease

Peter L. M. Jansen

Aktuelle Ausgaben

Neu im Fachgebiet Innere Medizin

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Innere Medizin und bleiben Sie gut informiert – ganz bequem per eMail.

© Springer Medizin 

Bildnachweise